Impact of regular attendance by infectious disease specialists on the management of hospitalised adults with community-acquired febrile syndromes

Clinical Microbiology and Infection

Volumn 10, Issue 10, 2004, Pages 911-916

  Borer, A ^a   Gilad, J ^a   Meydan, N ^a   Schlaeffer, P ^a   Riesenberg, K ^a   Schlaeffer, F ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Antibiotic use; Appropriate therapy; Febrile syndromes; Infectious disease specialists

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CLINDAMYCIN; CLOXACILLIN; ERYTHROMYCIN; IMIPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; ROXITHROMYCIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMMUNICABLE DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG COST; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORTALITY; PHYSICIAN; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; SKIN INFECTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINARY TRACT INFECTION;

EID: 6444243526     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00964.x     Document Type: Article

References (19)

1. McGowan JE, Tenover FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997; 11: 297-311.
2. Shales DM, Gerding DN, John JF et al. Society for Healthcare Epidemiology of America and the Infectious Disease Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997; 18: 275-291.
3. Tice AD. Editorial response: impact of infectious diseases specialists. Clin Infect Dis 1999; 29: 67-68.
4. Byl B, Clevenbergh P, Jacobs F et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999; 29: 60-66.
5. Classen DC, Burke JP, Wenzel RP. Infectious diseases consultations: impact on outcomes for hospitalized patients and results of a preliminary study. Clin Infect Dis 1997; 24: 468-470.
6. Cunney RJ, McNamara EB, Alansari N, Loo B, Smyth EG. The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteremia. J Clin Pathol 1997; 50: 1010-1012.
7. Fluckiger U, Zimmerli W, Sax H, Frei R, Widmer AF. Clinical impact of an infectious disease service on the management of bloodstream infection. Eur J Clin Microbiol Infect Dis 2000; 19: 493-500.
8. Gomez J, Conde Cavero SJ, Hernandez Cardona JL et al. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother 1999; 38: 309-314.
9. Wilkins EG, Hickey MM, Khoo S et al. Northwick Park Infection Consultation Service. Part II. Contribution of the service to patient management: an analysis of results between September 1987 and July 1990. J Infect 1991; 23: 57-63.
10. Fowler VG, Sanders LL, Sexton DJ et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendation of infectious disease specialists: experience with 244 patients. Clin Infect Dis 1998; 27: 478-486.
11. Nathwani D, Davey P, France AJ, Phillips G, Orange G, Parratt D. Impact of an infection consultation service for bacteraemia on clinical management and use of resources. Q J Med 1996; 89: 789-797.
12. Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD. Cost effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affair Medical Center from 1987 to 1989. Am J Med 1987; 90: 439-444.
13. Molstad S, Cars O. Major changes in the use of antibiotics following a national programme. Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). Scand J Infect Dis 1999; 31: 191-195.
14. Gould IM, Jappy B. Trends in hospital antimicrobial prescribing after 9 years of stewardship. J Antimicrob Chemother 2000; 45: 913-917.
15. Briceland LL, Nightingale CH, Quintiliani R, Cooper BW, Smith KS. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. Arch Intern Med 1998; 148: 2019-2022.
16. Quintiliani R, Cooper BW, Briceland LL, Nightingale CH. Economic impact of streamlining antibiotic administration. Am J Med 1987; 82: 391-394.
17. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Disease Society of America. J Infect Dis 1987; 157: 869-876.
18. Gould IM, Jappy B. Trends in hospital antibiotic prescribing after introduction of an antibiotic policy. J Antimicrob Chemother 1996; 38: 895-904.
19. John JF, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997; 24: 471-485.